Zai Lab - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsZai Lab

Zai Lab(ZLAB)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

breast neoplasms

,

multiple myeloma

,

urinary bladder neoplasms

,

transitional cell carcinoma

,

,

thymus neoplasms

,

,

small cell lung carcinoma

,

,

urinary bladder neoplasms

,

,

non-hodgkin lymphoma

,

Globulin, immune

,

immunoglobulin light-chain amyloidosis

,

,

kidney transplantation

,

lupus nephritis

,

,

b-cell chronic lymphocytic leukemia

,

hemolytic anemia autoimmune

,

anti-neutrophil cytoplasmic antibody-associated vasculitis

,

glomerulonephritis

,

t-cell lymphoma

,

hodgkin disease

,

follicular lymphoma

,

b-cell lymphoma

,

t-cell lymphoma cutaneous

,

bronchiolitis obliterans syndrome

,

psychology rejection

,

kidney diseases

,

,

,

hemolytic anemia

,

graft vs host disease

,

multiple myeloma

,

plasma cell neoplasms

,

lymphoid leukemia

,

,

neuromyelitis optica

,

iga glomerulonephritis

,

,

,

myasthenia gravis

,

chronic renal insufficiency

,

left ventricular dysfunction

,

ventricular dysfunction

,

,

hypophosphatasia

,

,

respiratory distress syndrome

,

severe acute respiratory syndrome

,

,

acute lung injury

,

paroxysmal hemoglobinuria

,

Histone-arginine methyltransferase carm1

,

,

penile induration

,

,

retinal vein occlusion

,

,

muscle spasticity

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use